200 likes | 210 Views
Doctors For Life International: An NGO’s perspective on Malaria in Southern Africa Bola Omoniyi, Ph.D. http: www.doctorsforlifeinternational.com. Who we are NGO, NPO Founded in 1991 Over 1300 Medical professionals 75% Africa based HQ: South Africa Operations in SADC countries. What we do
E N D
Doctors For Life International: An NGO’s perspective on Malaria in Southern AfricaBola Omoniyi, Ph.D. http: www.doctorsforlifeinternational.com
Who we are NGO, NPO Founded in 1991 Over 1300 Medical professionals 75% Africa based HQ: South Africa Operations in SADC countries What we do Malaria R & D (Artemisia) Access to Medicines Care of Orphans & Vulnerable Children Home Based (AIDS) Care Life Skills Education WorkPlace AIDS Programs Care of Abused Women Doctors For Life (DFL) International
Education Life Skills Based HIV/AIDS Prevention
Developing Artemisia for Treatment of Malaria in Poor and Rural Communities
Malaria – Southern Africa • South Africa: Decreasing incidence of malaria • Mozambique: Primary cause of ill health. • 40% of outpatients, 60% of pediatric patients • One third of all hospital deaths • More than 90% of children infected in most areas • Significant contributor to high infant & under- 5 mortality • 15-30% deaths in pregnant women. • Poor rural communities with little medical access most affected. • Angola: Number one killer
Malaria Map – Southern Africa Department of Health RSA
Plasmodium Falciparum • Majority of cases in South Africa • Most South Africans are non-immune • Low altitude areas of NE S. Africa • P. vivax and P.ovale are rare • Seasonal Transmission: Oct - May
Quinine Artemisinin derivatives Mefloquine Tetracyclines Clindamycin Chloroquine Halofantrine Available Anti-Malarials
Choice of Treatment • Severity of malaria • Resistance pattern • Parasite species • Patient characteristic – age, pregnancy • Geography; Kwazulu-Natal, Limpopo, Mpumalanga
Products under Development • Doctors For Life International (DFL): Artemisia • South African Traditional Medicines Group (SATMERG): Screening of Plant extracts. 25/500 plants with anti-malarial activity identified. • National Bioproducts Institute (BPI): Rapid malaria diagnostic kit ( designed for use in rural areas) Ongoing Research: • South African Malaria Initiative (SAMI): drug discovery, diagnostics and epidemiology • National Institute of Communicable Diseases (NICD): Insecticide resistance • University of Cape Town (UCT): Mechanism of chloroquine resistance reversal
Artemisia based product Capsules Under preclinical and clinical development Pilot study in the DRC Doctors For Life: Malarlife
Mozambique: Decreasing Malaria Related Mortality in Children
Doctors For Life: Future Goals • Development of effective and affordable artemisia-based treatment for Malaria • Combining artemisia with other effective and affordable products to tackle recrudescence • Establish a permanent presence in Mozambique and Angola • Expand care of orphans and vulnerable children • Expand HIV prevention programs • Increase effective collaboration with other organizations and international agencies working on Malaria & HIV/AIDS